Treatment planning and imaging market to reach $4.22 billion by 2030

The treatment planning systems and advanced image processing market is projected to grow from $2.51 billion in 2025 to $2.79 billion in 2026, with North America leading and Asia-Pacific expected to grow fastest. Demand is being fueled by cancer care, chronic disease management, and wider use of AI and cloud-based tools in healthcare.

Why it matters: - Treatment planning systems and advanced image processing tools help clinicians improve precision in radiation therapy and surgery. - The market’s growth reflects rising demand for more accurate cancer care, chronic disease management, and personalized treatment. - The category is also tied to broader shifts in healthcare technology, including AI, cloud platforms, and real-time monitoring.

What happened: - The market was valued at $2.51 billion in 2025 and is projected to reach $2.79 billion in 2026. - The 2025 to 2026 forecast implies a 11.2% compound annual growth rate. - The market is expected to reach $4.22 billion by 2030, growing at a 10.9% CAGR from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Market growth is being driven by rising cancer and chronic disease rates, imaging technology advances, wider acceptance of radiation therapy, precision medicine adoption, and better healthcare infrastructure. - Future demand is expected to come from personalized oncology, AI-driven treatment planning, cloud-based healthcare platforms, improved imaging in emerging economies, and real-time monitoring with adaptive radiotherapy. - The report flags multi-modality imaging integration, customized treatment protocols, real-time image-guided therapies, collaborative cloud platforms, and predictive analytics as key trends. - The technologies use software and imaging tools to design and optimize therapeutic procedures. - Advanced image processing improves visualization, helps target treatment areas more precisely, and supports better clinical results. - Chronic disease burden is a major growth catalyst because long-term conditions require ongoing diagnosis, treatment planning, and monitoring. - A CDC report cited in the release said 76.4% of Americans had at least one chronic condition in 2023. - The same CDC report said prevalence ranged from 59.5% among younger adults to 93.0% among older adults. - The company also said the 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspots infographics, and updated graphics and tables. - The release included sample and full-report links: Download a free sample and View the full report.

Between the lines: - The forecast points to a market moving beyond hardware and into software-led clinical workflow tools. - AI, cloud connectivity and predictive analytics are becoming part of treatment planning, not just add-ons. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific as healthcare systems expand and modernize.

What's next: - The market is expected to keep expanding as oncology care becomes more personalized and image-guided treatment becomes more common. - Adoption of adaptive radiotherapy and real-time monitoring should increase as hospitals look for more precise and efficient care pathways. - The report’s next update cycle will likely track how AI-enabled planning and cloud platforms move from emerging trends to standard practice.